Drug Profile
Influenza A virus vaccine H7N9 - Adimmune Corporation
Alternative Names: AdimFlu-ALatest Information Update: 17 Jan 2018
Price :
$50
*
At a glance
- Originator Adimmune Corporation
- Class Influenza A vaccines; Influenza A virus H7N9 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Influenza A virus H7N9 subtype